dc.contributor.author | Kelly, Daniel | |
dc.date.accessioned | 2022-02-03T16:49:46Z | |
dc.date.available | 2022-02-03T16:49:46Z | |
dc.date.issued | 2021 | en |
dc.date.submitted | 2021 | en |
dc.identifier.citation | Daniel Kelly, 'Affinity-bound growth factor within sulfated interpenetrating network bioinks for bioprinting cartilaginous tissues', 2021, Acta Biomaterialia;, 128; | en |
dc.identifier.other | Y | |
dc.description.abstract | 3D bioprinting has emerged as a promising technology in the field of tissue engineering and regenerative
medicine due to its ability to create anatomically complex tissue substitutes. However, it still remains
challenging to develop bioactive bioinks that provide appropriate and permissive environments to in-
struct and guide the regenerative process in vitro and in vivo. In this study alginate sulfate, a sulfated
glycosaminoglycan (sGAG) mimic, was used to functionalize an alginate-gelatin methacryloyl (GelMA) in-
terpenetrating network (IPN) bioink to enable the bioprinting of cartilaginous tissues. The inclusion of
alginate sulfate had a limited influence on the viscosity, shear-thinning and thixotropic properties of the
IPN bioink, enabling high-fidelity bioprinting and supporting mesenchymal stem cell (MSC) viability post-
printing. The stiffness of printed IPN constructs greatly exceeded that achieved by printing alginate or
GelMA alone, while maintaining resilience and toughness. Furthermore, given the high affinity of algi-
nate sulfate to heparin-binding growth factors, the sulfated IPN bioink supported the sustained release
of transforming growth factor-β3 (TGF-β3), providing an environment that supported robust chondroge-
nesis in vitro, with little evidence of hypertrophy or mineralization over extended culture periods. Such
bioprinted constructs also supported chondrogenesis in vivo, with the controlled release of TGF-β3 pro-
moting significantly higher levels of cartilage-specific extracellular matrix deposition. Altogether, these
results demonstrate the potential of bioprinting sulfated bioinks as part of a ‘single-stage’ or ‘point-of-
care’ strategy for regenerating cartilaginous tissues | en |
dc.format.extent | 130-142 | en |
dc.language.iso | en | en |
dc.relation.ispartofseries | Acta Biomaterialia; | |
dc.relation.ispartofseries | 128; | |
dc.rights | Y | en |
dc.subject | 3D bioprinting | en |
dc.subject | Bioinks | en |
dc.subject | tissue substitutes | en |
dc.subject.lcsh | 3D bioprinting | en |
dc.subject.lcsh | Bioinks | en |
dc.subject.lcsh | tissue substitutes | en |
dc.title | Affinity-bound growth factor within sulfated interpenetrating network bioinks for bioprinting cartilaginous tissues | en |
dc.type | Journal Article | en |
dc.type.supercollection | scholarly_publications | en |
dc.type.supercollection | refereed_publications | en |
dc.identifier.peoplefinderurl | http://people.tcd.ie/kellyd9 | |
dc.identifier.rssinternalid | 237805 | |
dc.identifier.doi | http://dx.doi.org/10.1016/j.actbio.2021.04.016 | |
dc.rights.ecaccessrights | openAccess | |
dc.identifier.orcid_id | 0000-0003-4091-0992 | |
dc.identifier.uri | http://hdl.handle.net/2262/98036 | |